What smart money is saying about T. Rowe Price
TROW
No fund has written a full thesis on T. Rowe Price in our archive, but 3 fund letters report a position in it — most recently Baillie Gifford Global Income Growth in June 2026.
Get an email when a fund buys, sells or pitches it
3
Reported positions
0
Bought
2
Sold
3
Letters
Position history
Every position in T. Rowe Price on record in the archive was reported in Q2 2026, across 3 fund letters, with 2 sells (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 3 | 0 | 2 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 3 positions · 3 moves
- June 2026
“In one case this quarter, the answer was an unambiguous no. When we first invested in T. Rowe Price, we admired its culture of long-termism and its genuine commitment to client service. But the structural shift towards passive alternatives has proven more relentless than we anticipated, fee pressure has shown no sign of abating, and outflows have continued to compound the problem. The world has changed for asset managers and T. Rowe has not kept pace with it. We sold the position and have reinvested the proceeds elsewhere.”
T. Rowe Price - June 2026
“In one case this quarter, the answer was an unambiguous no. When we first invested in T. Rowe Price, we admired its culture of long-termism and its genuine commitment to client service. But the structural shift towards passive alternatives has proven more relentless than we anticipated, fee pressure has shown no sign of abating, and outflows have continued to compound the problem. The world has changed for asset managers and T. Rowe has not kept pace with it. We sold the position and have reinvested the proceeds elsewhere.”
T. Rowe Price - June 2026
“Once a year in our Quality Growth Review, we test whether the companies we own are doing what we bought them to do. We strip out currency effects, disposals, tax wheezes and accounting noise and we compare each holding’s clean earnings growth with the 10% rate that we seek. The slide on screen summarises this exercise. The portfolio-level result was reassuring: five-year earnings growth is on target. But the spread beneath that average matters. Some holdings are compounding well above our hurdle. Some are simply in cyclical troughs. But others prompt a tougher question: is compounding interrupted, or has it been disrupted? Would we buy this company today, knowing what we now know? This led to the sale of T. Rowe Price.”
T. Rowe Price
Read the letters behind these T. Rowe Price positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger